HistologiX is excited to announce that we have entered a strategic partnership with Antibody Analytics, a leading provider of immunology research services and characterisation of antibody-targeted therapeutics. This partnership will allow us to expand our offering to include a range of cutting-edge antibody testing services, ensuring that our customers have access to the most advanced technology and expertise in the industry.
Antibody Analytics has a long history of providing high-quality, reliable cell-based solutions to clients across a wide range of industries. Their cutting-edge technology and expertise make them an ideal partner for HistologiX, and we are confident that this partnership will provide significant benefits to our customers.
"We are delighted to be partnering with Antibody Analytics, their commitment to providing high-quality research services aligns perfectly with our own values, and we are excited to work together to offer even more advanced solutions to our customers and strengthen our offerings."
"HistologiX is one of the leaders in histology, image analysis and digital pathology and through this collaboration, Antibody Analytics is now able to provide more comprehensive support to our customers with target discovery, pre-clinical and clinical histology analysis needs. Antibody Analytics offers comprehensive in vitro immunopharmacology and immunotoxicology services from the very earliest stages of the drug discovery process, starting from target discovery, through lead identification and selection to product characterization. Our partnership with HistologiX will expand this to immunohistochemical efficacy & toxicity biomarker assays (pre-clinical and clinical) and tissue cross reactivity (TCR) assessments. This is an exciting opportunity for both companies and allows expansion of our capabilities from early discovery to clinical testing for targeted biologics."
We are thrilled to be partnering with Antibody Analytics and look forward to offering our customers even more advanced testing solutions. As always, our priority is to provide the highest-quality services to our customers, and this partnership is an important step in achieving that goal.
You can learn more about Antibody Analytics and our strategic partnerships here.
